Opportunity to benefit over 2 million patients annually

Our solution is driven to address a clear patient need that is supported by data.

Since 2014, when the FDA placed a black box warning on power morcellators, surgeons have been searching for a solution to safely and effectively approach minimally invasive specimen removal.  

Based on recent Journal of the American Medical Association (JAMA) data, we know that minimally invasive surgery decreases the rate of complications post-surgery and should always be an option in pre-operation decision making.

The Eximis lap specimen removal device enables physicians to offer the option for minimally invasive surgery with a neat specimen removal protocol.

The solution has the potential to impact approximately 2 million lives through minimally invasive procedures annually. 

market potential chart

Eximis impact